Compare Elder Pharma with J.B.Chemicals - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs J.B.CHEMICALS - Comparison Results

J.B.CHEMICALS 
   Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ELDER PHARMA J.B.CHEMICALS ELDER PHARMA/
J.B.CHEMICALS
 
P/E (TTM) x -0.2 15.6 - View Chart
P/BV x 0.1 2.1 4.7% View Chart
Dividend Yield % 0.0 0.5 -  

Financials

 ELDER PHARMA   J.B.CHEMICALS
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
J.B.CHEMICALS
Mar-18
ELDER PHARMA/
J.B.CHEMICALS
5-Yr Chart
Click to enlarge
High Rs380363 104.7%   
Low Rs188255 73.7%   
Sales per share (Unadj.) Rs491.2169.1 290.4%  
Earnings per share (Unadj.) Rs-3.216.6 -19.2%  
Cash flow per share (Unadj.) Rs14.423.4 61.5%  
Dividends per share (Unadj.) Rs02.00 0.0%  
Dividend yield (eoy) %00.6 0.0%  
Book value per share (Unadj.) Rs376.5172.5 218.3%  
Shares outstanding (eoy) m20.5483.57 24.6%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x0.61.8 31.6%   
Avg P/E ratio x-89.318.6 -479.4%  
P/CF ratio (eoy) x19.713.2 149.3%  
Price / Book Value ratio x0.81.8 42.1%  
Dividend payout %012.0 0.0%   
Avg Mkt Cap Rs m5,83325,827 22.6%   
No. of employees `000NA3.8 0.0%   
Total wages/salary Rs m2,1792,511 86.8%   
Avg. sales/employee Rs ThNM3,747.4-  
Avg. wages/employee Rs ThNM665.7-  
Avg. net profit/employee Rs ThNM367.8-  
INCOME DATA
Net Sales Rs m10,08914,135 71.4%  
Other income Rs m257366 70.1%   
Total revenues Rs m10,34614,501 71.3%   
Gross profit Rs m-7922,178 -36.4%  
Depreciation Rs m361570 63.4%   
Interest Rs m2,75635 7,897.7%   
Profit before tax Rs m-3,6531,940 -188.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m3,7130-   
Tax Rs m125552 22.7%   
Profit after tax Rs m-651,387 -4.7%  
Gross profit margin %-7.815.4 -50.9%  
Effective tax rate %-3.428.5 -12.0%   
Net profit margin %-0.69.8 -6.6%  
BALANCE SHEET DATA
Current assets Rs m9,24010,470 88.3%   
Current liabilities Rs m9,9982,749 363.7%   
Net working cap to sales %-7.554.6 -13.7%  
Current ratio x0.93.8 24.3%  
Inventory Days Days4655 83.9%  
Debtors Days Days6078 77.2%  
Net fixed assets Rs m10,1245,811 174.2%   
Share capital Rs m206167 123.1%   
"Free" reserves Rs m5,58214,248 39.2%   
Net worth Rs m7,73414,416 53.6%   
Long term debt Rs m4,8890-   
Total assets Rs m22,88217,649 129.7%  
Interest coverage x-0.356.6 -0.6%   
Debt to equity ratio x0.60-  
Sales to assets ratio x0.40.8 55.1%   
Return on assets %11.88.1 145.9%  
Return on equity %-0.89.6 -8.8%  
Return on capital %22.313.7 162.9%  
Exports to sales %3.00-   
Imports to sales %0.40-   
Exports (fob) Rs m307NA-   
Imports (cif) Rs m43NA-   
Fx inflow Rs m3076,164 5.0%   
Fx outflow Rs m1251,334 9.4%   
Net fx Rs m1814,829 3.8%   
CASH FLOW
From Operations Rs m11,7541,231 955.2%  
From Investments Rs m-561-208 269.3%  
From Financial Activity Rs m-6,762-595 1,136.1%  
Net Cashflow Rs m4,432427 1,037.6%  

Share Holding

Indian Promoters % 39.6 55.4 71.5%  
Foreign collaborators % 0.0 0.3 -  
Indian inst/Mut Fund % 7.5 3.4 221.2%  
FIIs % 16.8 3.9 430.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 36.1 37.0 97.6%  
Shareholders   16,479 30,437 54.1%  
Pledged promoter(s) holding % 77.6 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ELDER PHARMA With:   DR. REDDYS LAB  IPCA LABS  JUBILANT LIFE SCIENCES  AUROBINDO PHARMA  PIRAMAL ENTERPRISES  

Compare ELDER PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Stock Markets Remain in Green This Week: Is the Rebound Here?(Podcast)

After a long period of underperformance, stock markets traded in green territory throughout the week. So, is this is a trend reversal and is the bottom forming in the market?

Related Views on News

J.B.CHEMICALS Announces Quarterly Results (4QFY19); Net Profit Up 91.2% (Quarterly Result Update)

May 24, 2019 | Updated on May 24, 2019

For the quarter ended March 2019, J.B.CHEMICALS has posted a net profit of Rs 422 m (up 91.2% YoY). Sales on the other hand came in at Rs 4 bn (up 18.9% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

J.B.CHEMICALS 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of J.B.CHEMICALS for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of J.B.CHEMICALS. Also includes updates on the valuation of J.B.CHEMICALS.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

Two Stocks to Buy in the Great Indian Festival(Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ELDER PHARMA SHARE PRICE


Sep 12, 2016 (Close)

TRACK ELDER PHARMA

  • Track your investment in ELDER PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ELDER PHARMA - LUPIN COMPARISON

COMPARE ELDER PHARMA WITH

MARKET STATS